<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=30011"><dc:title>AV-optimized conduction system pacing for treatment of AV dromotropathy</dc:title><dc:creator>Zupan Mežnar,	Anja	(Avtor)
	</dc:creator><dc:creator>Mrak,	Miha	(Avtor)
	</dc:creator><dc:creator>Mullens,	Wilfried	(Avtor)
	</dc:creator><dc:creator>Štublar,	Jernej	(Avtor)
	</dc:creator><dc:creator>Ivanovski,	Maja	(Avtor)
	</dc:creator><dc:creator>Žižek,	David	(Avtor)
	</dc:creator><dc:subject>AV coupling</dc:subject><dc:subject>AV dromotropathy</dc:subject><dc:subject>AV dyssynchrony</dc:subject><dc:subject>conduction system pacing</dc:subject><dc:subject>first‐degree AV block</dc:subject><dc:description>Background: Severe first-degree atrioventricular (AV) block may produce symptoms similar to heart failure due to AV dyssynchrony, a syndrome termed AV dromotropathy. According to guidelines, it should be considered for permanent pacemaker implantation, yet evidence supporting this treatment is scarce. Objectives: This study aimed to determine the impact of AV-optimized conduction system pacing (CSP) in patients with symptomatic severe first-degree AV block and echocardiographic signs of AV dyssynchrony. Methods: Patients with symptomatic first-degree AV block (PR &gt; 250 ms), preserved left ventricular ejection fraction, narrow QRS, and AV dyssynchrony were included in the study. In a single-blind cross-over design, patients were randomized to AV sequential CSP or backup VVI pacing with a base rate of 40 bpm. We compared exercise capacity, echocardiographic parameters, and symptom occurrence at the end of 3 months of each period. Results: Fourteen patients completed the study. During the AV-optimized CSP compared to the backup pacing period, patients achieved a higher workload on exercise test (147.2 ± 50.9 vs. 140.7 ± 55.8 W; p = .032), with a trend towards higher peak VO2 (23.3 ± 7.1 vs. 22.8 ± 7.1 mL/min/kg; p = .224), and higher left ventricular stroke volume (LVSV 74.5 ± 13.8 vs. 66.4 ± 12.5 mL; p &lt; .001). Symptomatic improvement was recorded, with fewer patients reporting general tiredness and 71% of patients preferring the AV-optimized CSP (p = .008). Conclusions: AV-optimized CSP could improve symptoms, exercise capacity and LVSV in patients with severe first-degree AV block</dc:description><dc:date>2024</dc:date><dc:date>2026-06-11 13:08:16</dc:date><dc:type>Neznano</dc:type><dc:identifier>30011</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
